Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.8%

1 terminated/withdrawn out of 131 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

13%

17 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed trials have results

Key Signals

39 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
38(40.0%)
N/A
33(34.7%)
Phase 3
15(15.8%)
Phase 1
6(6.3%)
Phase 4
2(2.1%)
Early Phase 1
1(1.1%)
95Total
Phase 2(38)
N/A(33)
Phase 3(15)
Phase 1(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (131)

Showing 20 of 131 trials
NCT07590596Not Yet Recruiting

Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer

Role: lead

NCT07013461Recruiting

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Role: collaborator

NCT07561983Phase 2Not Yet Recruiting

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

Role: lead

NCT05191485Recruiting

Shared Decision Making in Patients With Lung Cancer

Role: lead

NCT06836869Not ApplicableRecruiting

Modified Tumor-free Techniques Operation to Cervical Cancer

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07388758Phase 2Not Yet Recruiting

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT07294872Phase 1Not Yet Recruiting

A Study of TIL in Advanced Solid Tumors (CZ)

Role: collaborator

NCT07338396Not Yet Recruiting

A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients

Role: collaborator

NCT06524427Not ApplicableRecruiting

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

Role: collaborator

NCT06518655Recruiting

Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

Role: collaborator

NCT07269912Not Yet Recruiting

Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer

Role: lead

NCT06007586Phase 3Completed

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Role: lead

NCT06561308Phase 2Recruiting

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Role: collaborator

NCT05189730Phase 2Active Not Recruiting

Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC

Role: lead

NCT07137052Not Yet Recruiting

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar

Role: collaborator

NCT06241612Phase 3Recruiting

Individualized Elective Neck Irradiation in NPC Patients

Role: collaborator

NCT07172087Not ApplicableNot Yet Recruiting

Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy

Role: lead

NCT06244537Not ApplicableRecruiting

Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer

Role: lead

NCT04555226Not ApplicableRecruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Role: collaborator